The Enterprise Value as of December 2025 (TTM) for Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) is 3.86B

According to Cabio Biotech (Wuhan) Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.86B. This represents a change of 1.43% compared to the average of 3.80B of the last 4 quarters.

Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) Historical Enterprise Value (quarterly & annually)

How has 688089.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of Cabio Biotech (Wuhan) Co., Ltd. over the last ten years is 3.95B. The current 3.86B Enterprise Value has changed 9.67% with respect to the historical average. Over the past ten years (40 quarters), 688089.SS's Enterprise Value was at its highest in in the September 2020 quarter at 6.32B. The Enterprise Value was at its lowest in in the June 2024 quarter at 2.11B.

Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cabio Biotech (Wuhan) Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) Average Enterprise Value

How has 688089.SS Enterprise Value performed in the past?

The current Enterprise Value of Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) Enterprise Value vs. Peers

How is 688089.SS’s Enterprise Value compared to its peers?

Cabio Biotech (Wuhan) Co., Ltd.’s Enterprise Value is greater than Baolingbao Biology Co.,Ltd. (3.52B), greater than Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (3.80B), less than Qingdao Vland Biotech Inc. (4.11B), less than Hvsen Biotechnology Co., Ltd. (4.42B), greater than Shanghai ZJ Bio-Tech Co., Ltd. (1.36B), less than Shanghai Hile Bio-Technology Co., Ltd. (3.88B), greater than Zhejiang Wecome Pharmaceutical Company Limited (3.42B), less than Hainan Huluwa Pharmaceutical Group Co., Ltd. (4.69B), greater than Guanhao Biotech Co.,Ltd. (3.79B), greater than Yantai Zhenghai Biotechnology Co., Ltd. (3.61B),

Build a custom stock screener for Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cabio Biotech (Wuhan) Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cabio Biotech (Wuhan) Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.